CITIC Securities Co., Ltd.(600030)
Search documents
十大券商策略:看好“有新高”组合!
天天基金网· 2026-01-05 01:05
上天天基金APP搜索777注册即可领500元券包,优选基金10元起投!限量发放!先到先得! 中信证券:人心思涨,预计开年市场震荡向上 从机构的赚钱效应来看,2025年在过去10年里能排到第三,过去20年里排到第六。在一个回头来看巨大 的结构性牛市当中,实际上市场既享受了预期差带来的"估值的钱",也挣到了"业绩的钱",预期差来自于 对中国自主科技能力的重估以及中美关系,而结构性的超预期业绩来自复杂贸易环境下外需的韧性以及AI 推理需求爆发,这些因素站在2025年初来看并不是那么理所应当会发生。增量流动性只是预期差和业绩 兑现过程中的结果,或者是用于后验的解释牛市形成的理由,投资者过于高估了增量资金对市场的影响。 增量资金入市不会是2026年市场上一个新台阶的主要因素。2026年最大的预期差来自于外需与内需的平 衡,对外"征税"、补贴内需应是大势所趋,今年是个重要的开端。站在开年,考虑到去年末的资金热度并 不算高,人心思涨的环境下开年后市场震荡向上的概率更高。 国泰海通:一年之计在于春 在市场持续反弹之际,中国股市有望跨越与站稳重要关口。海外流动性的宽松,叠加春节前结汇,有望推 动人民币的稳定与升值。以A500E ...
中信证券:旅游市场红火开局,离岛免税复苏强劲
Di Yi Cai Jing· 2026-01-05 01:05
中信证券研报表示,2026年文旅市场迎来开门红,元旦假期全国国内出游人次、出游总花费分别较2024 年元旦假期增长约5%/6%,国内旅游大盘表现符合预期,出入境人次超预期。其中免税数据表现超预 期,离岛免税销售额较2024年元旦假期高增约50%,政策红利持续释放,免税商积极推出促销活动。酒 店间夜增长亮眼,价格较2024年元旦仍有缺口。景区普遍表现较好,头部山岳型景区尤为亮眼。今年春 节连休9天,出行景气度有望持续提升,建议密切关注旅游市场表现。 ...
从估值重估走向业绩驱动 2026年中国股市将延续涨势
Shang Hai Zheng Quan Bao· 2026-01-05 00:45
展望2026年,中信证券认为,虽然2025年末沪指走出11连阳,但市场整体的"躁动"仍然非常克制。大部 分前期兑现收益的资金目前还在等待入场时机,这也意味着在没有重大超预期风险的情况下,市场难有 明显的调整。站在开年时点,人心思涨的环境下市场震荡向上的概率更高。 中期维度下,中信证券建议投资者以"赚业绩的钱而不期待估值的钱"的思维布局。"A股不仅是中国的A 股,也是全球的A股。"中信证券首席A股策略分析师裘翔此前在2026年资本市场年会上表示。他认为, A股公司正陆续从本国敞口的本土化企业转型为全球敞口的跨国公司,中国资本市场也正从新兴市场逐 步转型为成熟市场。"十五五"期间,中国企业在全球价值链分配中的位置有望进一步抬升,把份额优势 转化为定价权,这是A股行情持续走强的基础。 中金公司策略团队则将2026年A股定义为"乘势笃行":国际货币秩序重构逻辑进一步强化,AI革命进入 应用关键期,我国创新产业迎来业绩兑现,上述趋势将继续支持中国资产表现。与此同时,经历一定估 值修复后,2026年A股基本面重要性将继续提升,全球资金和国内居民资金动向也是不可忽视的因素。 1月5日,A股迎来2026年首个交易日。 202 ...
亿纬锂能递表港交所 中信证券为独家保荐人
Zheng Quan Shi Bao Wang· 2026-01-05 00:28
公司在全球拥有8个生产基地和2个在建生产基地,销售公司及办公室覆盖7个国家及地区,售后服务网 络覆盖24个国家及地区。 市场地位(按2024年出货量计),在全球消费电池制造商中名列第三,市场份额为11.7%。在全球储能 电池市场名列第二,市场份额为17.2%。 全球消费电池出货量预计2025—2029年复合年增长率达26.2%。全球电动汽车销量预计2025—2029年复 合年增长率达20.1%。全球储能电池年出货量预计2025—2029年复合年增长率达23.1%。 亿纬锂能向港交所主板递交上市申请,中信证券为其独家保荐人。亿纬锂能是全球少数在消费电池、动 力电池及储能电池领域均全球领先,能够服务社会经济全场景应用的锂电池平台企业,产品广泛应用于 智能生活、绿色交通和能源转型。 (文章来源:证券时报网) ...
臻驱科技递表港交所 中信证券、国泰海通为联席保荐人
Zheng Quan Shi Bao Wang· 2026-01-05 00:19
Core Viewpoint - Zhenqu Technology has submitted its listing application to the Hong Kong Stock Exchange, with CITIC Securities and Guotai Junan as joint sponsors. The company focuses on electric vehicle (EV) control solutions and has developed a layered solution set that includes power modules, motor controllers, and power bricks, allowing customers to choose different levels of system integration [1] Group 1: Company Overview - Zhenqu Technology pioneered the concept of "power brick" and achieved mass production of the main drive power brick in 2021, significantly simplifying the assembly of control systems, enhancing platform reusability, and shortening development cycles [1] - The company has expanded its offerings to low-power controllers and domain controllers in the power domain and chassis domain [1] Group 2: Market Position and Achievements - As of September 30, 2025, the company has secured 50 design wins from 13 OEMs, with solutions applied to 82 vehicle models, 54 of which have entered mass production [1] - According to Frost & Sullivan, the company's rankings in the Chinese market by installation volume are as follows: - Motor controllers ranked 11th in 2024 and 8th in the first nine months of 2025 - Dual motor controllers ranked 3rd in the first nine months of 2025 - Main drive power bricks ranked 1st in 2024 and 2nd in the first nine months of 2025 - Power bricks installed in dual motor controllers ranked 1st in the first nine months of 2025 - Power modules ranked 8th in 2024 and 7th in the first nine months of 2025 [1] Group 3: Business Expansion - The company has leveraged its core technology to expand its business into emerging fields such as electric vertical takeoff and landing vehicles (eVTOL) and embodied intelligence [1]
益方生物递表港交所 独家保荐人为中信证券
Zheng Quan Shi Bao Wang· 2026-01-04 23:52
核心临床阶段产品D-2570正在开展斑片状银屑病及溃疡性结肠炎(UC)的注册性III期临床试验,并计 划启动针对银屑病关节炎(PsA)、系统性红斑狼疮(SLE)及白癜风的额外临床试验。泰瑞司群为口 服选择性雌激素受体降解剂(SERD),正在开展ER+/HER2-乳腺癌的注册性III期临床试验。 全球及中国在肿瘤药物、靶向肿瘤药物、银屑病药物、UC药物及SERD药物市场均显示出显著的增长潜 力,例如中国靶向肿瘤药物市场预计到2035年将达到616亿美元。 截至2025年12月24日,公司已建立了全面且差异化的产品管线,包括两款商业化产品、两款临床阶段核 心产品、一款临床阶段候选产品及三个临床前候选产品。 已商业化产品中,贝福替尼(BPI-D0316)为自主研发的第三代EGFR酪氨酸激酶抑制剂,用于治疗 EGFR突变阳性的非小细胞肺癌(NSCLC),已在中国获批上市并纳入《国家医保药品目录》。格索雷 塞(D-1553)为自主研发的KRAS G12C抑制剂,是国内该靶点领域首个进入临床阶段的自研产品,已 在中国获批上市并纳入《国家医保药品目录》。公司已与正大天晴签署协议,授予其在中国内地开发、 注册、生产及商业化格 ...
收藏!十大券商首席解码2026投资策略!
Zheng Quan Shi Bao Wang· 2026-01-04 23:39
Group 1 - The core viewpoint is that 2026 will be a crucial year for China's economic work, marking the beginning of the "15th Five-Year Plan" and the transition to a period of solid foundation and comprehensive efforts [1] - Analysts from ten major securities firms provide insights on market trends, industry allocations, and major investment opportunities for 2026, aiming to clarify the investment landscape for investors [1] Group 2 - CITIC Securities predicts that A-share company profit growth will show a trend of low growth initially followed by a recovery [2] - The market is expected to be influenced by the US-China trade agreement and the US midterm elections, with three phases of market performance anticipated [4] - Key investment themes include global pricing power in manufacturing, the expansion of Chinese companies overseas, the continuation of the tech trend with AI, and the potential recovery of domestic demand [4] Group 3 - CICC highlights that the restructuring of international order and China's industrial innovation will support A-share performance, with a market trend of initial growth followed by stabilization [5] - Analysts suggest focusing on growth sectors such as AI applications, industries benefiting from external demand, and cyclical sectors nearing recovery [7] Group 4 - GF Securities indicates that the A-share market is likely to maintain a "slow bull" pattern, with corporate profit structures undergoing significant changes [8][10] - The expected nominal GDP growth for China in 2026 is projected to reach 6.45%, significantly higher than in 2025, supporting the overall improvement in corporate profits [21] Group 5 - Analysts from various firms suggest that the market will shift from valuation-driven to profit-driven dynamics, with traditional and emerging industries contributing to profit recovery [15][17] - The focus on new production capabilities and the impact of policies like "anti-involution" are expected to improve competition in traditional industries and boost domestic demand [17] Group 6 - Analysts predict that more industries will enter a profit recovery phase in 2026, with nominal economic recovery and price increases being the most evident trends [18][20] - UBS forecasts that A-share company profit growth could rise to 8% due to improved nominal GDP growth and the narrowing of PPI declines [32] Group 7 - Analysts recommend focusing on four main investment themes: technological self-reliance, consumer sector recovery, "anti-involution" related sectors, and the global competitiveness of Chinese companies [34] - The market is expected to maintain a balanced style between growth and value, with cyclical sectors likely to outperform defensive sectors as the economy recovers [34]
收藏!十大券商首席,解码2026投资策略!
Xin Lang Cai Jing· 2026-01-04 23:35
中信证券裘翔:A股公司盈利增速将呈现前低后高态势 中信证券首席A股策略师裘翔认为,2026年A股公司盈利增速将呈现前低后高态势。 作者:许盈、孙翔峰、胡飞军、刘艺文、马静、王蕊 2026年是"十五五"规划开局之年,基本实现社会主义现代化这场接力跑,即将进入"夯实基础、全面发 力的关键时期",做好经济工作至关重要。 为更全面展现市场机构对2026年经济形势、政策走向与投资布局的前瞻思考,证券时报·券商中国记者 特邀请十家券商首席策略分析师,围绕2026年市场趋势、行业板块配置思路、重大主题投资机会等发表 见解与展望,希望通过十大首席的专业视角,为投资者厘清脉络、把握机遇提供有力参考,共同助力资 本市场健康发展和国家现代化建设。 炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 他分析,中美格局决定了行情节奏,行情可能将被中美签署贸易协议和美国中期选举分为三段:第一阶 段从当前到中美贸易协议落地前,市场上涨斜率预计放缓;第二阶段是协议落地到美国中期选举结束, A股有望在稳定的外部环境下迎来持续上涨;第三阶段是美国中期选举结束后,外部扰动的不确定性可 能会急剧提高,投资者需要把视野重心转回国 ...
收藏!十大券商首席,解码2026投资策略!
券商中国· 2026-01-04 23:34
作者:许盈、 孙翔峰、 胡飞军、 刘艺文、 马静、 王蕊 2026年是"十五五"规划开局之年,基本实现社会主义现代化这场接力跑,即将进入"夯实基础、全面发力的关键时期",做好经济工作至关重要。 为更全面展现市场机构对2026年经济形势、政策走向与投资布局的前瞻思考,证券时报·券商中国记者特邀请十家券商首席策略分析师,围绕2026年市场趋势、行业 板块配置思路、重大主题投资机会等发表见解与展望,希望通过十大首席的专业视角,为投资者厘清脉络、把握机遇提供有力参考,共同助力资本市场健康发展和 国家现代化建设。 中信证券裘翔:A股公司盈利增速将呈现前低后高态势 中信证券首席A股策略师裘翔认为,2026年A股公司盈利增速将呈现前低后高态势。 他分析,中美格局决定了行情节奏,行情可能将被中美签署贸易协议和美国中期选举分为三段:第一阶段从当前到中美贸易协议落地前,市场上涨斜率预计放缓; 第二阶段是协议落地到美国中期选举结束,A股有望在稳定的外部环境下迎来持续上涨;第三阶段是美国中期选举结束后,外部扰动的不确定性可能会急剧提高, 投资者需要把视野重心转回国内。 裘翔认为,从主题投资机会和板块配置来看,四大线索值得重视:一是制 ...
券商竞争激烈 头部效应显著
Zheng Quan Ri Bao· 2026-01-04 23:26
Core Insights - The capital market showed a positive trend in 2025, with active trading reflected in the significant increase in transaction volume on the Longhu list, reaching 3.34 trillion yuan, a year-on-year growth of over 40% [1][2] - The competition among brokerage firms intensified, with notable changes in the rankings of the top 100 brokerage departments, highlighting the emergence of several "dark horse" firms [1][3] Group 1: Market Performance - In 2025, a total of 7,029 brokerage departments appeared on the Longhu list 123,900 times, with a total transaction volume of 3.34 trillion yuan, marking a 42.6% increase year-on-year [2] - The top 100 brokerage departments accounted for 2.26 trillion yuan of the total transaction volume, representing 67.66% of the market share, indicating a strong head effect [2] Group 2: Top Brokerage Departments - The "Lhasa team" under Dongfang Caifu Securities maintained a strong performance, occupying three of the top ten positions, with the Lhasa Tuanjie Road No. 1 Securities Department leading with a transaction volume of 127.87 billion yuan [2] - New entrants to the top ten include Kaiyuan Securities' Xi'an Xidajie Securities Department, which rose from 27th place in 2024 to 3rd in 2025, and several other firms that significantly improved their rankings [2][3] Group 3: Emerging Firms and Foreign Participation - Several "dark horse" brokerage departments made significant leaps in rankings, such as Guotai Junan's Shanghai Jing'an District New Zha Road Securities Department, which rose from 559th to 14th place [3] - The presence of foreign brokerage firms is increasing, with six foreign brokerage departments making it into the top 50, including UBS and Goldman Sachs, showcasing their growing influence in the market [4] Group 4: Industry Trends - The competition in brokerage business has intensified, reflecting differences in client scale, market share, and overall strength among various firms, as well as the strategic focus on regional development by branch offices [5] - The Longhu list serves as an important indicator of market sentiment and hotspots, with sectors like general equipment, chemical products, computer software, automotive, and semiconductors attracting significant investment [6]